Sanofi Us Services Drug Patent Portfolio

Sanofi Us Services owns 2 orange book drugs protected by 21 US patents Given below is the list of Sanofi Us Services's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10369291 Mechanism for a drug delivery device 16 Sep, 2035
Active
US9345750 Long-acting formulations of insulin 18 May, 2031
Active
US7918833 Pen-type injector 23 Mar, 2028
Active
US7918833 Pen-type injector 23 Sep, 2027
Active
US8679069 Pen-type injector 12 Apr, 2025
Active
US8512297 Pen-type injector 15 Sep, 2024 Expired
US9561331 Drive mechanisms suitable for use in drug delivery devices 28 Aug, 2024 Expired
US9623189 Relating to drive mechanisms suitable for use in drug delivery devices 19 Aug, 2024 Expired
US9533105 Drive mechanisms suitable for use in drug delivery devices 17 Aug, 2024 Expired
US9604009 Drive mechanisms suitable for use in drug delivery devices 16 Aug, 2024 Expired
US8992486 Pen-type injector 05 Jun, 2024 Expired
US9011391 Pen-type injector 26 Mar, 2024 Expired
US8556864 Drive mechanisms suitable for use in drug delivery devices 03 Mar, 2024 Expired
US8603044 Pen-type injector 02 Mar, 2024 Expired
US9233211 Relating to a pen-type injector 02 Mar, 2024 Expired
US9408979 Pen-type injector 02 Mar, 2024 Expired
US9526844 Pen-type injector 02 Mar, 2024 Expired
US9604008 Drive mechanisms suitable for use in drug delivery devices 02 Mar, 2024 Expired
US9610409 Drive mechanisms suitable for use in drug delivery devices 02 Mar, 2024 Expired
US9775954 Pen-type injector 02 Mar, 2024 Expired
US9827379 Drive mechanisms suitable for use in drug delivery devices 02 Mar, 2024 Expired


Given below is the list of recent legal activities going on the following drug patents of Sanofi Us Services.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 8th Year, Large Entity 08 Nov, 2023 US9345750
Payment of Maintenance Fee, 8th Year, Large Entity 08 Nov, 2023 US9345750
Payment of Maintenance Fee, 4th Year, Large Entity 25 Jan, 2023 US10369291
Payment of Maintenance Fee, 4th Year, Large Entity 25 Jan, 2023 US10369291
Post Issue Communication - Certificate of Correction 13 Nov, 2019 US10369291
Post Issue Communication - Certificate of Correction 13 Nov, 2019 US10369291
Payment of Maintenance Fee, 4th Year, Large Entity 08 Nov, 2019 US9345750
Payment of Maintenance Fee, 4th Year, Large Entity 08 Nov, 2019 US9345750
Recordation of Patent Grant Mailed 06 Aug, 2019 US10369291
Recordation of Patent Grant Mailed 06 Aug, 2019 US10369291
Patent Issue Date Used in PTA Calculation 06 Aug, 2019 US10369291
Patent Issue Date Used in PTA Calculation 06 Aug, 2019 US10369291
Email Notification 18 Jul, 2019 US10369291
Email Notification 18 Jul, 2019 US10369291
Issue Notification Mailed 17 Jul, 2019 US10369291


Sanofi Us Services's Drug Patent Litigations

Sanofi Us Services's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Sep 10, 2018, against patent number US8992486. The petitioner Mylan Pharmaceuticals Inc et al., challenged the validity of this patent, with Sanofi-Aventis Deutschland GmbH et al. as the respondent. Click below to track the latest information on how companies are challenging Sanofi Us Services's patents.

Patent Proceeding Filing Date Status Respondent Petitioner
Patent litigations
US8679069 May, 2019 FWD Entered
(11 Aug, 2020)
Sanofi-Aventis Deutschland Pfizer Inc.
US8603044 September, 2018 FWD Entered
(29 May, 2020)
Sanofi-Aventis Deutschland GmbH Mylan Pharmaceuticals Inc.
US8992486 September, 2018 FWD Entered
(29 May, 2020)
Sanofi-Aventis Deutschland GmbH Mylan Pharmaceuticals Inc.
US8992486 October, 2018 FWD Entered
(29 May, 2020)
Sanofi-Aventis Deutschland GmbH Mylan Pharmaceuticals Inc.
US9526844 September, 2018 FWD Entered
(29 May, 2020)
Sanofi-Aventis Deutschland GmbH Mylan Pharmaceuticals Inc
US9526844 September, 2018 FWD Entered
(29 May, 2020)
Sanofi-Aventis Deutschland GmbH Mylan Pharmaceuticals Inc.
US9604008 September, 2018 FWD Entered
(29 May, 2020)
Sanofi-Aventis Deutschland GmbH Mylan Pharmaceuticals Inc.
US8679069 September, 2018 FWD Entered
(02 Apr, 2020)
Sanofi-Aventis Deutshland GmbH Mylan Pharmaceuticals Inc.
US9526844 May, 2019 Terminated-Other
(20 Aug, 2019)
Sanofi-Aventis Deutschland Pfizer Inc.
US9526844 May, 2019 Terminated-Other
(19 Aug, 2019)
Sanofi-Aventis Deutschland Pfizer Inc.
US8603044 May, 2019 Terminated-Other
(15 Aug, 2019)
Sanofi-Aventis Deutschland Pfizer Inc.
US8992486 May, 2019 Terminated-Other
(15 Aug, 2019)
Sanofi-Aventis Deutschland Pfizer Inc.
US9604008 May, 2019 Terminated-Other
(15 Aug, 2019)
Sanofi-Aventis Deutschland Pfizer Inc.
US9526844 September, 2018 Terminated-Denied
(03 Apr, 2019)
Sanofi-Aventis Deutschland GmbH Mylan Pharmaceuticals Inc.
US8992486 September, 2018 Terminated
(19 Dec, 2018)
Sanofi-Aventis Deutschland GmbH et al. Mylan Pharmaceuticals Inc et al.


Sanofi Us Services's Family Patents


Family Patents



Sanofi Us Services Drug List

Given below is the complete list of Sanofi Us Services's drugs and the patents protecting them.


1. Toujeo Max Solostar

Toujeo Max Solostar is protected by 20 patents, out of which 16 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10369291 Mechanism for a drug delivery device 16 Sep, 2035
(10 years from now)
Active
US9345750 Long-acting formulations of insulin 18 May, 2031
(6 years from now)
Active
US7918833 Pen-type injector 23 Sep, 2027
(2 years from now)
Active
US8679069 Pen-type injector 12 Apr, 2025
(4 months from now)
Active
US8512297 Pen-type injector 15 Sep, 2024
(2 months ago)
Expired
US9561331 Drive mechanisms suitable for use in drug delivery devices 28 Aug, 2024
(3 months ago)
Expired
US9623189 Relating to drive mechanisms suitable for use in drug delivery devices 19 Aug, 2024
(3 months ago)
Expired
US9533105 Drive mechanisms suitable for use in drug delivery devices 17 Aug, 2024
(3 months ago)
Expired
US9604009 Drive mechanisms suitable for use in drug delivery devices 16 Aug, 2024
(3 months ago)
Expired
US8992486 Pen-type injector 05 Jun, 2024
(6 months ago)
Expired
US9011391 Pen-type injector 26 Mar, 2024
(8 months ago)
Expired
US8556864 Drive mechanisms suitable for use in drug delivery devices 03 Mar, 2024
(9 months ago)
Expired
US8603044 Pen-type injector 02 Mar, 2024
(9 months ago)
Expired
US9233211 Relating to a pen-type injector 02 Mar, 2024
(9 months ago)
Expired
US9408979 Pen-type injector 02 Mar, 2024
(9 months ago)
Expired
US9526844 Pen-type injector 02 Mar, 2024
(9 months ago)
Expired
US9604008 Drive mechanisms suitable for use in drug delivery devices 02 Mar, 2024
(9 months ago)
Expired
US9610409 Drive mechanisms suitable for use in drug delivery devices 02 Mar, 2024
(9 months ago)
Expired
US9775954 Pen-type injector 02 Mar, 2024
(9 months ago)
Expired
US9827379 Drive mechanisms suitable for use in drug delivery devices 02 Mar, 2024
(9 months ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Toujeo Max Solostar's drug page


2. Toujeo Solostar

Toujeo Solostar is protected by 21 patents, out of which 16 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10369291 Mechanism for a drug delivery device 16 Sep, 2035
(10 years from now)
Active
US9345750 Long-acting formulations of insulin 18 May, 2031
(6 years from now)
Active
US7918833
(Pediatric)
Pen-type injector 23 Mar, 2028
(3 years from now)
Active
US7918833 Pen-type injector 23 Sep, 2027
(2 years from now)
Active
US8679069 Pen-type injector 12 Apr, 2025
(4 months from now)
Active
US8512297 Pen-type injector 15 Sep, 2024
(2 months ago)
Expired
US9561331 Drive mechanisms suitable for use in drug delivery devices 28 Aug, 2024
(3 months ago)
Expired
US9623189 Relating to drive mechanisms suitable for use in drug delivery devices 19 Aug, 2024
(3 months ago)
Expired
US9533105 Drive mechanisms suitable for use in drug delivery devices 17 Aug, 2024
(3 months ago)
Expired
US9604009 Drive mechanisms suitable for use in drug delivery devices 16 Aug, 2024
(3 months ago)
Expired
US8992486 Pen-type injector 05 Jun, 2024
(6 months ago)
Expired
US9011391 Pen-type injector 26 Mar, 2024
(8 months ago)
Expired
US8556864 Drive mechanisms suitable for use in drug delivery devices 03 Mar, 2024
(9 months ago)
Expired
US8603044 Pen-type injector 02 Mar, 2024
(9 months ago)
Expired
US9233211 Relating to a pen-type injector 02 Mar, 2024
(9 months ago)
Expired
US9408979 Pen-type injector 02 Mar, 2024
(9 months ago)
Expired
US9526844 Pen-type injector 02 Mar, 2024
(9 months ago)
Expired
US9604008 Drive mechanisms suitable for use in drug delivery devices 02 Mar, 2024
(9 months ago)
Expired
US9610409 Drive mechanisms suitable for use in drug delivery devices 02 Mar, 2024
(9 months ago)
Expired
US9775954 Pen-type injector 02 Mar, 2024
(9 months ago)
Expired
US9827379 Drive mechanisms suitable for use in drug delivery devices 02 Mar, 2024
(9 months ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Toujeo Solostar's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List